Bloomberg News

Cochlear Recall of Ear Implant May Cost A$100 Million, UBS Says

October 17, 2011

Oct. 17 (Bloomberg) -- Cochlear Ltd.’s recall of its N5 ear implants may cost about A$100 million, UBS AG health-care analysts Andrew Goodsall and Dan Hurren said in a report today.

To contact the editor responsible for this story: Jason Gale at j.gale@bloomberg.net


Tim Cook's Reboot
LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus